Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, suggesting a potential new area of therapeutic investigation. The findings, published in the Oct. 22 online issue of Nature Genetics, were surprising given that MALAT1, a long non-coding RNA (lncRNA), previously was described as a metastasis promoter.
“Our six-year study unearthed the unexpected metastasis-suppressing function of MALAT1 through highly rigorous genetics approaches,” said Li Ma, Ph.D., associate professor of Experimental Radiation Oncology and principal investigator for the study. “Our findings defy the conclusions drawn from previous MALAT1 studies and suggest the potential value of therapeutic agents targeting a cellular pathway linked to MALAT1. However, this will require further clinical investigation.”
Halting a key protein behind metastasis
Ma’s team observed that MALAT1 sequestered and inactivated a protein known as TEAD, a transcription factor, which when combined with a “co-activator” called YAP, causes cancer proliferation and metastatic progression. The researchers discovered that MALAT1 binds and inactivates TEAD, preventing it from partnering with YAP and targeting genes in promoting metastasis.
Although MALAT1 had been associated with metastasis, the team, using a breast cancer transgenic mouse model, inactivated the MALAT1 gene without altering expression of its adjacent genes and observed that MALAT1 inactivation promoted lung metastasis, which was reversed when MALAT1 was re-introduced.
Similarly, knockout of MALAT1 in human breast cancer cells induced their metastatic ability, which was reversed by the re-introduction of MALAT1. Additionally, overexpression of MALAT1 suppressed breast cancer metastasis in several mouse models.
“Taken together, our study reveals the unexpected function of MALAT1 through comprehensive gene targeting and genetic rescue approaches in multiple in vivo models,” said Ma. “These findings call for a reassessment of ongoing efforts to target MALAT1 as an anti-metastatic therapeutic strategy, and provide a general framework for pursuing a better understanding of lncRNAs.”
RNA promotes metastasis in lung cancer
Long noncoding RNA MALAT1 suppresses breast cancer metastasis, Nature Genetics (2018). DOI: 10.1038/s41588-018-0252-3 , https://www.nature.com/articles/s41588-018-0252-3
December 17, 2018
December 16, 2018
December 16, 2018
- Tailored Feedback at CRC Screen Improves Lifestyle Behaviors
- Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
- How the Mediterranean Diet Can Help Women’s Hearts
- Sustained connections associated with symptoms of autism
- Concussion rates among young football players were higher than previously reported
- Cresco Labs granted approval to operate marijuana dispensary in Ohio
- Study provides insight into health risks facing new mothers
- AMSBIO expands Wnt signaling pathway product range to aid research
- Surgical treatment unnecessary for many prostate cancer patients
- Excess weight responsible for cancers globally finds report
- Regular sex associated with greater enjoyment of life in seniors
- Social stigma contributes to poor mental health in the autistic community
- Multidisciplinary team successfully performs complex surgery on patient suffering from enlarged skull
- Experts analyze data that can guide antidepressant discontinuation
- Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
- Siblings of children with autism or ADHD are at elevated risk for both disorders
- New project aims to understand why and how metabolic disorders develop in patients
- Diets containing GM maize have no harmful effects on health or metabolism of rats
- Are doctors and teachers confusing immaturity and attention deficit?
- Hearing loss linked with increased risk for premature death